Epithelial cell migration (promotion of re-epithelialization)

"Epithelial cell migration/promotion of reepithelialization" refers to the **biological process** by which epithelial cells—primarily keratinocytes—move into a wound site and proliferate to restore the integrity of damaged epithelium. This process is essential for effective skin wound closure. It involves complex interactions among chemical signaling molecules such as cytokines and growth factors (e.g., EGF, TGF-beta), extracellular matrix components that provide structural support and guidance cues, enzymes like matrix metalloproteinases that remodel tissue barriers, and cellular cross-talk between keratinocytes and fibroblasts. The process can be disrupted by chronic inflammation, infection, diabetes mellitus, hypoxia/ischemia at the tissue level, or excessive exudate production. Impaired reepithelialization leads to delayed healing or chronic wounds with increased risk of complications such as hypertrophic scarring or infection[1][3][5][7][8]. **Note:** This entry does **not** represent a single molecular target but rather describes a physiological process involving multiple molecules (receptors/enzymes/signaling pathways). Therefore: *is_target*: false *is_incorrect*: true The term should be replaced with specific molecular targets involved in this process—such as "Epidermal growth factor receptor," "Integrin beta 3," "Matrix metalloproteinase 9," etc.—for structured therapeutic targeting information.

Other names

Re-epithelializationwound epithelializationepithelial wound healingkeratinocyte migration

Therapies act by providing scaffolding for cell migration, delivering exogenous growth factors to stimulate keratinocyte proliferation and movement, modulating inflammation to create a favorable environment for healing[1][3].